These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9229959)

  • 1. [The significance of specific oligonucleotides in clinical medicine and their use in the treatment of patients with infective diseases].
    Bojić I
    Vojnosanit Pregl; 1996; 53(5):399-408. PubMed ID: 9229959
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Message therapy: gene therapy that targets mRNA sequence and stability.
    Kozarsky KF; Couture LA
    Am J Hum Genet; 1997 Oct; 61(4):790-4. PubMed ID: 9382086
    [No Abstract]   [Full Text] [Related]  

  • 6. Oligonucleotide therapeutics: a step forward.
    Gewirtz AM
    J Clin Oncol; 2000 May; 18(9):1809-11. PubMed ID: 10784620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
    Sommer W; Heilig M
    Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense therapy in malignant diseases: status quo and quo vadis?
    Tamm I
    Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.
    Dowdy SF; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):107-108. PubMed ID: 29782220
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisense oligonucleotide technology in the development of cancer therapeutics.
    Tseng BY; Brown KD
    Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisense treatment of viral infection.
    Whitton JL
    Adv Virus Res; 1994; 44():267-303. PubMed ID: 7817875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisense oligonucleotides arrest the synthesis of disease promoting proteins].
    Schnädelbach S
    Med Monatsschr Pharm; 1998 Dec; 21(12):394-5. PubMed ID: 9925458
    [No Abstract]   [Full Text] [Related]  

  • 14. Antisense oligonucleotides and the rational design of new antitumor drugs.
    Prieto J; Hernández-Alcoceba R
    Rev Esp Enferm Dig; 2005 Jul; 97(7):467-71. PubMed ID: 16262525
    [No Abstract]   [Full Text] [Related]  

  • 15. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method.
    Yildiz D; Oztas H; Hilal Ates B
    Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic perspectives on antisense oligonucleotides].
    Mazza P
    Boll Chim Farm; 1992 Nov; 131(10):355-62. PubMed ID: 1296702
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene-modified cells for the treatment of cancer.
    Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM
    Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.